Note 11 - Research and Development - Components of Research and Development Expenses (Details) $ in Thousands, $ in Thousands |
12 Months Ended | ||||
|---|---|---|---|---|---|
|
Dec. 31, 2017
USD ($)
|
Dec. 31, 2016
USD ($)
|
Dec. 31, 2016
CAD ($)
|
Dec. 31, 2015
USD ($)
|
Dec. 31, 2015
CAD ($)
|
|
| Statement Line Items [Line Items] | |||||
| Research and Development excluding salaries | $ 4,573 | $ 4,860 | $ 3,131 | ||
| CrystalGenomics Option Fee (a) | 1,000 | ||||
| Salaries | 1,451 | 1,691 | 1,528 | ||
| Stock-based compensation | 214 | 247 | 183 | ||
| Depreciation of equipment | 36 | 36 | 23 | ||
| $ 6,274 | $ 7,834 | $ 10,322 | $ 4,865 | $ 6,254 | |
| X | ||||||||||
- Definition Amount of research and development expense excluding salaries. No definition available.
|
| X | ||||||||||
- Definition The amount of expenditure directly attributable to depreciation included in research or development activities, recognised in profit or loss. No definition available.
|
| X | ||||||||||
- Definition Amount of option fee incurred related to research and development. No definition available.
|
| X | ||||||||||
- Definition The amount of expenditure directly attributable to salaries included in research or development activities, recognised in profit or loss. No definition available.
|
| X | ||||||||||
- Definition The amount of expenditure directly attributable to stock-based compensation included in research or development activities, recognised in profit or loss. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of expenditure directly attributable to research or development activities, recognised in profit or loss. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|